on 13 janvier 2025 at 7:26 AM bioMĂ©rieux renforce sa prĂ©sence sur le marchĂ© du diagnostic dĂ©localisĂ© (« Point of Care ») avec l’acquisition de SpinChip Diagnostics, une start-up spĂ©cialisĂ©e dans les tests immunoessais au plus prĂšs du patient
RepubliĂ© via Innoreader Read More  Marcy lâĂtoile, France, January 13th 2025 â bioMĂ©rieux, a world leader in the field of in vitro diagnostics, announces that it has entered into an agreement to acquire SpinChip Diagnostics ASA (âSpinChipâ), a privately held Norwegian diagnostics company that has developed a game-changing immunoassay diagnostics platform. The small benchtop […]